Analytical strategy for the detection of undeclared stimulants and anorectic compounds in dietary supplements using the Agilent 6550 iFunnel Q-TOF LC/MS

Significance of the Topic

The adulteration of botanical weight-loss supplements with undeclared synthetic stimulants and anorectic compounds represents a growing public health concern. Consumers who assume they are using ‘‘natural’’ products may be exposed to potent pharmaceuticals such as sibutramine and caffeine, leading to cardiovascular and neurological side effects. A reliable, high‐throughput analytical strategy is essential to safeguard consumer health and enforce regulatory compliance.

Objectives and Study Overview

This work aimed to establish a streamlined workflow for the unambiguous detection and quantitation of undeclared synthetic anorectic and stimulant agents in commercial dietary supplements. The study leveraged high‐resolution accurate‐mass Q‐TOF LC/MS technology in combination with Agilent’s Forensic PCDL AM library and advanced data‐mining tools. Three market‐obtained slimming products (two powders and one soft‐gel capsule) were screened to evaluate the approach’s sensitivity, selectivity, and efficiency.

Methodology and Instrumentation

Sample Preparation:

• Online purchase of products; 400 mg of powder or a capsule’s contents suspended in water and centrifuged.
• Direct injection of diluted supernatant and liquid–liquid extraction using ToxiTube A devices.
• Reconstitution in water for confirmation; serial dilutions (1/10 to 1/1000) for quantitation using external standards.

Instrumentation:

• Mass Spectrometry: Agilent 6550 iFunnel Q‐TOF LC/MS with ESI+, scan range m/z 40–1000, MS ALL ion acquisition at CE 0, 10, 20, 40 V, and targeted MS/MS at multiple collision energies.
• Chromatography: Agilent 1290 Infinity II LC System with ZORBAX Eclipse Plus C18 RRHT column (2.1 × 150 mm, 1.8 µm), gradient elution (5–95% methanol with 0.01% formic acid), 0.2 mL/min flow, 40 °C.
• Software: MassHunter Acquisition, Qualitative, Quantitative; Molecular Formula Generator (MFG); Molecular Structure Correlator (MSC).

Main Results and Discussion

The ‘‘Find by Formula’’ algorithm flagged multiple candidates from a custom Forensic PCDL AM of 80 anorectic analogues. Initial screening yielded high‐scoring hits for sibutramine and caffeine. ALL ION acquisition combined with coelution scoring (threshold >70%) reduced false positives, narrowing sibutramine candidates from seven to three. Targeted MS/MS with MFG provided an exact formula (C17H26ClN, 97% score, Δppm 0.39). MSC correlated fragment ions to the proposed structure, achieving a >91% match score. Confirmation against reference standards validated the presence of sibutramine in two of three samples at levels of 15 and 26 µg/mg and caffeine in two samples (0.1% and 2.0% w/w).

Benefits and Practical Applications

• High‐resolution accurate‐mass screening allows retrospective data mining for new adulterants.
• Multi‐mode acquisition (SCAN, ALL ION, Target MS/MS) streamlines identification with minimal sample preparation.
• Integrated MFG and MSC tools deliver structural confirmation without extensive manual interpretation.
• The workflow reduces analysis time and cost, enhancing laboratory throughput for QA/QC and forensic investigations.

Future Trends and Potential Uses

• Expansion of forensic accurate‐mass libraries to cover broader classes of illicit and designer compounds.
• Integration of machine learning algorithms to predict unknown adulterants and enhance retrospective screening.
• Miniaturized, field‐deployable HRMS platforms for on‐site rapid screening of dietary supplements.
• Adoption of standardized HRMS protocols by regulatory agencies for routine market surveillance.

Conclusion

This study demonstrates that Q‐TOF LC/MS paired with a dedicated forensic mass library and advanced data‐mining software provides an effective, rapid, and reliable method for detecting undeclared synthetic stimulants and anorectic drugs in dietary supplements. The approach combines high‐accuracy mass measurements, coelution scoring, and structural correlation to ensure confident identification and quantitation, supporting consumer safety and regulatory enforcement.

Reference

1. Khazan M., et al. Iran Red Crescent Med J, 16(3), 2014.
2. Mathon C., et al. Food Addit Contam Part A Chem Anal Control Expo Risk Assess, 31(1), 2014.
3. Yang L., et al. J Chromatogr Sci, 50(10), 2012.
4. Song F., et al. J Pharm Biomed Anal, 88, 136–143, 2014.
5. Budzikiewicz H., Djerassi C., Williams D.H. Mass Spectrometry of Organic Compounds. Holden-Day, 1967.
6. Kimble B.J. in M.L. Gross (Ed.), ACS Symposium Series 70, American Chemical Society, 1978.
7. Ramanathan R., et al. J Mass Spectrom, 46(6), 2011.
8. Hill A.W., Mortishire-Smith R.J.R. Rapid Commun Mass Spectrom, 19(21), 2005.